VMP 39697411000001109

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Levofloxacin 250mg tablets
BNF code 0501120X0AAABAB
Virtual Therapeutic Moiety Levofloxacin
Date identifier became valid 26 May 2021
Previous product identifier 324633007
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Levofloxacin hemihydrate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 387552007
Strength value numerator 250.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Evoxil 250mg tablets (Kent Pharma (UK) Ltd)
Levofloxacin 250mg tablets (Alliance Healthcare (Distribution) Ltd)
Levofloxacin 250mg tablets (Ipca Laboratories UK Ltd)
Levofloxacin 250mg tablets (Macleods Pharma UK Ltd)
Levofloxacin 250mg tablets (Medihealth (Northern) Ltd)
Levofloxacin 250mg tablets (Sigma Pharmaceuticals Plc)
Virtual Medicinal Product Packs
Levofloxacin 250mg tablets 10 tablet
Levofloxacin 250mg tablets 5 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.

Feedback